+关注
南瓜9
暂无个人介绍
IP属地:四川
5
关注
4
粉丝
0
主题
0
勋章
主贴
热门
南瓜9
2022-04-29
$Innate Pharma SA(IPHA)$
吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢
南瓜9
2021-12-16
$Innate Pharma SA(IPHA)$
这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌
南瓜9
2021-12-07
$老虎证券(TIGR)$
app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??
南瓜9
2021-12-03
$老虎证券(TIGR)$
感觉老虎 * app 这两天好卡,不会跑路吧[笑哭]
南瓜9
2021-12-03
$Innate Pharma SA(IPHA)$
**股没救了,头颈癌药物研发100%失败,即将开启大裁员
南瓜9
2021-07-10
$老虎证券(TIGR)$
谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。
南瓜9
2021-06-22
$Innate Pharma SA(IPHA)$
谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!
南瓜9
2021-05-28
$Innate Pharma SA(IPHA)$
这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。
南瓜9
2021-05-06
$Innate Pharma SA(IPHA)$
再不公布莫那利珠单抗的实验数据,股票就要跌没了
南瓜9
2020-10-27
$Innate Pharma SA(IPHA)$
有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3499232187175264,"uuid":"3499232187175264","gmtCreate":1536223321620,"gmtModify":1638877960719,"name":"南瓜9","pinyin":"ng9nangua9","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":5,"tweetSize":10,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.29","exceedPercentage":"80.00%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"四川","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":616094075,"gmtCreate":1651223671418,"gmtModify":1651223671418,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","text":"$Innate Pharma SA(IPHA)$吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/616094075","isVote":1,"tweetType":1,"viewCount":2827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690111004,"gmtCreate":1639646611133,"gmtModify":1639646611133,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","text":"$Innate Pharma SA(IPHA)$这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690111004","isVote":1,"tweetType":1,"viewCount":1595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606644475,"gmtCreate":1638877920560,"gmtModify":1638879155953,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","text":"$老虎证券(TIGR)$app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/606644475","isVote":1,"tweetType":1,"viewCount":3347,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3514329116425907","authorId":"3514329116425907","name":"小虎AV","avatar":"https://static.tigerbbs.com/162e12f8dcec770ec19f66f2abb0d5db","crmLevel":1,"crmLevelSwitch":0},"content":"您好 请问您的APP版本和手机型号多少?","text":"您好 请问您的APP版本和手机型号多少?","html":"您好 请问您的APP版本和手机型号多少?"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601645826,"gmtCreate":1638527387493,"gmtModify":1638527387493,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>感觉老虎 * app 这两天好卡,不会跑路吧[笑哭] ","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>感觉老虎 * app 这两天好卡,不会跑路吧[笑哭] ","text":"$老虎证券(TIGR)$感觉老虎 * app 这两天好卡,不会跑路吧[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/601645826","isVote":1,"tweetType":1,"viewCount":2070,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583240412144451","authorId":"3583240412144451","name":"花开。","avatar":"https://static.tigerbbs.com/2d822c65368a3bff0a5d2b1117ea115e","crmLevel":1,"crmLevelSwitch":0},"content":"我以为是手机问题,我也卡","text":"我以为是手机问题,我也卡","html":"我以为是手机问题,我也卡"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601645050,"gmtCreate":1638527334393,"gmtModify":1638527334393,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>**股没救了,头颈癌药物研发100%失败,即将开启大裁员","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>**股没救了,头颈癌药物研发100%失败,即将开启大裁员","text":"$Innate Pharma SA(IPHA)$**股没救了,头颈癌药物研发100%失败,即将开启大裁员","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601645050","isVote":1,"tweetType":1,"viewCount":1558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":141626785,"gmtCreate":1625869746047,"gmtModify":1625869746047,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","text":"$老虎证券(TIGR)$谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","images":[{"img":"https://static.tigerbbs.com/ab85a5ed843da0120d6757150e67a599","width":"1080","height":"2160"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/141626785","isVote":1,"tweetType":1,"viewCount":1522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":129828811,"gmtCreate":1624369305633,"gmtModify":1624369305633,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","text":"$Innate Pharma SA(IPHA)$谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/129828811","isVote":1,"tweetType":1,"viewCount":898,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":135238456,"gmtCreate":1622164605175,"gmtModify":1622164605175,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","text":"$Innate Pharma SA(IPHA)$这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/135238456","isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":105551153,"gmtCreate":1620312359072,"gmtModify":1620312359072,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>再不公布莫那利珠单抗的实验数据,股票就要跌没了","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>再不公布莫那利珠单抗的实验数据,股票就要跌没了","text":"$Innate Pharma SA(IPHA)$再不公布莫那利珠单抗的实验数据,股票就要跌没了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105551153","isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":301708581,"gmtCreate":1603754360543,"gmtModify":1703830563949,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","text":"$Innate Pharma SA(IPHA)$有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/301708581","isVote":1,"tweetType":1,"viewCount":2119,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0},"content":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!","text":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!","html":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":606644475,"gmtCreate":1638877920560,"gmtModify":1638879155953,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","text":"$老虎证券(TIGR)$app 好卡啊,老虎证券是不是出事了,千万别跑路啊,加载个首页自选股得10秒才能出来,是不是程序员把服务器给干掉了一部分?!!??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/606644475","isVote":1,"tweetType":1,"viewCount":3347,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3514329116425907","authorId":"3514329116425907","name":"小虎AV","avatar":"https://static.tigerbbs.com/162e12f8dcec770ec19f66f2abb0d5db","crmLevel":1,"crmLevelSwitch":0},"content":"您好 请问您的APP版本和手机型号多少?","text":"您好 请问您的APP版本和手机型号多少?","html":"您好 请问您的APP版本和手机型号多少?"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601645826,"gmtCreate":1638527387493,"gmtModify":1638527387493,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>感觉老虎 * app 这两天好卡,不会跑路吧[笑哭] ","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>感觉老虎 * app 这两天好卡,不会跑路吧[笑哭] ","text":"$老虎证券(TIGR)$感觉老虎 * app 这两天好卡,不会跑路吧[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/601645826","isVote":1,"tweetType":1,"viewCount":2070,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583240412144451","authorId":"3583240412144451","name":"花开。","avatar":"https://static.tigerbbs.com/2d822c65368a3bff0a5d2b1117ea115e","crmLevel":1,"crmLevelSwitch":0},"content":"我以为是手机问题,我也卡","text":"我以为是手机问题,我也卡","html":"我以为是手机问题,我也卡"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":141626785,"gmtCreate":1625869746047,"gmtModify":1625869746047,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","text":"$老虎证券(TIGR)$谁能跟我解释下这是怎么回事,突然我老虎的交易权限被暂停了,我都懵逼了。至少大半年没有动过账户了,也没有交易,一直有持仓,突然没权限了。","images":[{"img":"https://static.tigerbbs.com/ab85a5ed843da0120d6757150e67a599","width":"1080","height":"2160"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/141626785","isVote":1,"tweetType":1,"viewCount":1522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":301708581,"gmtCreate":1603754360543,"gmtModify":1703830563949,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","text":"$Innate Pharma SA(IPHA)$有几个非常重要的信息参考1、公司目前只有一款孤儿药Lumoxiti,一年收入几百万欧元,FDA已同意其合法性,并在美国可以完全商业化,欧盟已提交申请,最终批复结果时间应该在2021年3-4月份2、Lacutamab实验处于临床2期,上半年受困于分包商GMP缺陷被各国各大药监局临停大半年,重新申请GMP之后,已恢复大部分实验3、莫那单抗是公司非常重要的3期资产,可以说是公司能否成功转型商业阶段公司安身立命的重器,不过突然更改阿斯利康付款方式,应该是实验中阿斯利康发现有部分瑕疵,不如预期的完美,这个瑕疵是否能如期解决是关键。4、公司披露信息的能力堪忧,这只股票官网上没有找到前期任何跟阿斯利康的商业化付款协议的新闻,危机公关能力也堪忧。公司各季度的财报信息不太重视,没有积极的提交SEC,导致各APP均不能完整的看到各季度的财报及实验预期,公司也长时间不提交13K报告,投资者无法知晓阿斯利康、诺和、BFI等重要股东的增减持情况,部分对冲基金已经在3-6月清空坚持5、公司在肿瘤研究方面确实有一定实力,不过行业药品研发成功率依然是看天。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/301708581","isVote":1,"tweetType":1,"viewCount":2119,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0},"content":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!","text":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!","html":"真是日了狗了,唯一的药品Lumoxiti还特么放弃了,商业化失败!不仅仅是失去药品,商业化能力跟渠道让人绝望,即便购物研发出新药又能给人多大的想象空间!"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":616094075,"gmtCreate":1651223671418,"gmtModify":1651223671418,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","text":"$Innate Pharma SA(IPHA)$吃人的股票,除非是新药100%研发成功,不然市场不会给予想象,哪怕到了三期股票也不会涨一丢丢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/616094075","isVote":1,"tweetType":1,"viewCount":2827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":135238456,"gmtCreate":1622164605175,"gmtModify":1622164605175,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","text":"$Innate Pharma SA(IPHA)$这个公司大多数药物研发都是孤儿药赛道,孤儿药是很多公司都不愿意碰的药品,研发难度高,收回成本的概率低,不知道公司是不是有意为之,还有部分是二三线药物,都是一些区别于大众药比较另类的药品,即便研发成功,暴涨的概率低,这种公司真要成长起来没有个几十年不大可能。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/135238456","isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690111004,"gmtCreate":1639646611133,"gmtModify":1639646611133,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","text":"$Innate Pharma SA(IPHA)$这股票有毒,啥利好都没用,赛诺菲的实验启动了,也付了点钱,怎么着也得涨几个点吧,盘前还跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690111004","isVote":1,"tweetType":1,"viewCount":1595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601645050,"gmtCreate":1638527334393,"gmtModify":1638527334393,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>**股没救了,头颈癌药物研发100%失败,即将开启大裁员","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>**股没救了,头颈癌药物研发100%失败,即将开启大裁员","text":"$Innate Pharma SA(IPHA)$**股没救了,头颈癌药物研发100%失败,即将开启大裁员","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601645050","isVote":1,"tweetType":1,"viewCount":1558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":129828811,"gmtCreate":1624369305633,"gmtModify":1624369305633,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","text":"$Innate Pharma SA(IPHA)$谁能告诉我,这股票怎么了,好消息也跌,下跌已经养成习惯了?这股票需要啥利好消息才能涨啊!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/129828811","isVote":1,"tweetType":1,"viewCount":898,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":105551153,"gmtCreate":1620312359072,"gmtModify":1620312359072,"author":{"id":"3499232187175264","authorId":"3499232187175264","name":"南瓜9","avatar":"https://static.tigerbbs.com/35f6f7896d1b1dcb743aeaeb32141ee3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>再不公布莫那利珠单抗的实验数据,股票就要跌没了","listText":"<a href=\"https://laohu8.com/S/IPHA\">$Innate Pharma SA(IPHA)$</a>再不公布莫那利珠单抗的实验数据,股票就要跌没了","text":"$Innate Pharma SA(IPHA)$再不公布莫那利珠单抗的实验数据,股票就要跌没了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105551153","isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}